• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性手术治疗晚期上皮性卵巢癌后的残留疾病,第 2 部分:纳入专家 elicitation 以调整发表偏倚的网络荟萃分析。

Residual Disease After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 2: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias.

机构信息

Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.

Pan-Birmingham Gynaecological Oncology Cancer Centre, Birmingham, United Kingdom.

出版信息

Am J Ther. 2023;30(1):e56-e71. doi: 10.1097/MJT.0000000000001548. Epub 2022 Nov 1.

DOI:10.1097/MJT.0000000000001548
PMID:36048531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9812412/
Abstract

BACKGROUND

Previous work has identified a strong association between the achievements of macroscopic cytoreduction and improved overall survival (OS) after primary surgical treatment of advanced epithelial ovarian cancer. Despite the use of contemporary methodology, resulting in the most comprehensive currently available evidence to date in this area, opponents remain skeptical.

AREAS OF UNCERTAINTY

We aimed to conduct sensitivity analyses to adjust for potential publication bias, to confirm or refute existing conclusions and recommendations, leveraging elicitation to incorporate expert opinion. We recommend our approach as an exemplar that should be adopted in other areas of research.

DATA SOURCES

We conducted random-effects network meta-analyses in frequentist and Bayesian (using Markov Chain Montel Carlo simulation) frameworks comparing OS across residual disease thresholds in women with advanced epithelial ovarian cancer after primary cytoreductive surgery. Elicitation methods among experts in gynecology were used to derive priors for an extension to a previously reported Copas selection model and a novel approach using effect estimates calculated from the elicitation exercise, to attempt to adjust for publication bias and increase confidence in the certainty of the evidence.

THERAPEUTIC ADVANCES

Analyses using data from 25 studies (n = 20,927 women) all showed the prognostic importance of complete cytoreduction (0 cm) in both frameworks. Experts accepted publication bias was likely, but after adjustment for their opinions, published results overpowered the informative priors incorporated into the Bayesian sensitivity analyses. Effect estimates were attenuated but conclusions were robust in all analyses.

CONCLUSIONS

There remains a strong association between the achievement of complete cytoreduction and improved OS even after adjustment for publication bias using strong informative priors formed from an expert elicitation exercise. The concepts of the elicitation survey should be strongly considered for utilization in other meta-analyses.

摘要

背景

先前的研究已经确定,在对晚期上皮性卵巢癌进行初次手术治疗后,实现大体减瘤术的效果与提高总生存期(OS)之间存在很强的关联。尽管采用了当代方法,得出了迄今为止该领域最全面的现有证据,但反对者仍然持怀疑态度。

不确定性领域

我们旨在进行敏感性分析,以调整潜在的发表偏倚,确认或反驳现有结论和建议,并利用启发式方法纳入专家意见。我们建议采用我们的方法作为范例,应在其他研究领域采用。

数据来源

我们在频繁主义和贝叶斯(使用马尔可夫链蒙特卡罗模拟)框架中进行了随机效应网络荟萃分析,比较了在初次细胞减瘤手术后患有晚期上皮性卵巢癌的女性中,残留疾病阈值对 OS 的影响。利用妇科专家的启发式方法,为先前报道的 Copas 选择模型的扩展和使用从启发式练习中计算出的效应估计值的新方法提供了先验,以尝试调整发表偏倚并增加对证据确定性的信心。

治疗进展

使用来自 25 项研究(n = 20,927 名女性)的数据进行的分析在两个框架中均显示了完全细胞减瘤术(0 cm)的预后重要性。专家们认为发表偏倚很可能存在,但在调整了他们的意见后,发表的结果超过了纳入贝叶斯敏感性分析的信息性先验。尽管效应估计值有所减弱,但在所有分析中结论都是稳健的。

结论

即使使用从专家启发式调查中形成的强有力信息性先验来调整发表偏倚,完全细胞减瘤术的效果与提高 OS 之间仍然存在很强的关联。启发式调查的概念应强烈考虑用于其他荟萃分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2c0/9812412/809ca6fc5a82/ajt-30-e56-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2c0/9812412/f147ce657381/ajt-30-e56-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2c0/9812412/809ca6fc5a82/ajt-30-e56-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2c0/9812412/f147ce657381/ajt-30-e56-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2c0/9812412/809ca6fc5a82/ajt-30-e56-g002.jpg

相似文献

1
Residual Disease After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 2: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias.原发性手术治疗晚期上皮性卵巢癌后的残留疾病,第 2 部分:纳入专家 elicitation 以调整发表偏倚的网络荟萃分析。
Am J Ther. 2023;30(1):e56-e71. doi: 10.1097/MJT.0000000000001548. Epub 2022 Nov 1.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.超根治性(广泛)手术与标准手术治疗晚期上皮性卵巢癌的初步细胞减灭术。
Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD007697. doi: 10.1002/14651858.CD007697.pub3.
4
Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis.原发性手术治疗晚期上皮性卵巢癌后残余病灶阈值:系统评价和网络荟萃分析。第一部分
Am J Ther. 2023;30(1):e36-e55. doi: 10.1097/MJT.0000000000001584. Epub 2022 Dec 20.
5
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
6
Behavioural interventions for smoking cessation: an overview and network meta-analysis.行为干预戒烟:综述和网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 4;1(1):CD013229. doi: 10.1002/14651858.CD013229.pub2.
7
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer.每周紫杉醇联合卡铂与每 3 周紫杉醇联合卡铂一线治疗上皮性卵巢癌的疗效比较。
Cochrane Database Syst Rev. 2022 Feb 21;2(2):CD012007. doi: 10.1002/14651858.CD012007.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

引用本文的文献

1
Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis.原发性手术治疗晚期上皮性卵巢癌后残余病灶阈值:系统评价和网络荟萃分析。第一部分
Am J Ther. 2023;30(1):e36-e55. doi: 10.1097/MJT.0000000000001584. Epub 2022 Dec 20.

本文引用的文献

1
Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis.原发性手术治疗晚期上皮性卵巢癌后残余病灶阈值:系统评价和网络荟萃分析。第一部分
Am J Ther. 2023;30(1):e36-e55. doi: 10.1097/MJT.0000000000001584. Epub 2022 Dec 20.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
Residual disease after primary surgery for advanced epithelial ovarian cancer: expert elicitation exercise to explore opinions about potential impact of publication bias in a planned systematic review and meta-analysis.
上皮性卵巢癌术后残余病灶:专家意见征询,旨在探讨系统评价和荟萃分析中发表偏倚的潜在影响。
BMJ Open. 2022 Aug 29;12(8):e060183. doi: 10.1136/bmjopen-2021-060183.
4
Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study.制定医疗保健决策中结构化专家 elicitation 的参考协议:混合方法研究。
Health Technol Assess. 2021 Jun;25(37):1-124. doi: 10.3310/hta25370.
5
Neglect of publication bias compromises meta-analyses of educational research.忽视发表偏倚会损害教育研究的荟萃分析。
PLoS One. 2021 Jun 3;16(6):e0252415. doi: 10.1371/journal.pone.0252415. eCollection 2021.
6
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
7
Investigating and dealing with publication bias and other reporting biases in meta-analyses of health research: A review.系统评价中健康研究的发表偏倚和其他报告偏倚的调查和处理:综述。
Res Synth Methods. 2021 Mar;12(2):248-259. doi: 10.1002/jrsm.1468. Epub 2020 Nov 18.
8
A historical review of publication bias.出版偏倚的历史回顾。
Res Synth Methods. 2020 Nov;11(6):725-742. doi: 10.1002/jrsm.1452. Epub 2020 Sep 17.
9
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
10
Assessment of Publication Bias and Systematic Review Findings in Top-Ranked Otolaryngology Journals.评估顶尖耳鼻喉科期刊的发表偏倚和系统评价结果。
JAMA Otolaryngol Head Neck Surg. 2019 Feb 1;145(2):187-188. doi: 10.1001/jamaoto.2018.3301.